ABCG2 p.Thr362Ala

Predicted by SNAP2: A: N (82%), C: N (82%), D: N (78%), E: N (82%), F: N (87%), G: N (82%), H: N (93%), I: N (78%), K: N (82%), L: N (82%), M: N (82%), N: N (87%), P: N (87%), Q: N (87%), R: N (78%), S: N (97%), V: N (87%), W: N (66%), Y: N (93%),
Predicted by PROVEAN: A: N, C: N, D: N, E: N, F: N, G: N, H: N, I: N, K: N, L: N, M: N, N: N, P: N, Q: N, R: N, S: N, V: N, W: D, Y: N,

[switch to compact view]
Comments [show]
Publications
[hide] Xie Y, Xu K, Linn DE, Yang X, Guo Z, Shimelis H, Nakanishi T, Ross DD, Chen H, Fazli L, Gleave ME, Qiu Y
The 44-kDa Pim-1 kinase phosphorylates BCRP/ABCG2 and thereby promotes its multimerization and drug-resistant activity in human prostate cancer cells.
J Biol Chem. 2008 Feb 8;283(6):3349-56. Epub 2007 Dec 5., 2008-02-08 [PMID:18056989] [PubMed]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Natarajan K, Bhullar J, Shukla S, Burcu M, Chen ZS, Ambudkar SV, Baer MR
The Pim kinase inhibitor SGI-1776 decreases cell surface expression of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and drug transport by Pim-1-dependent and -independent mechanisms.
Biochem Pharmacol. 2013 Feb 15;85(4):514-24. doi: 10.1016/j.bcp.2012.12.006. Epub 2012 Dec 19., [PMID:23261525] [PubMed]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Zhang W, Meng Y, Liu N, Wen XF, Yang T
Insights into Chemoresistance of Prostate Cancer.
Int J Biol Sci. 2015 Aug 1;11(10):1160-70. doi: 10.7150/ijbs.11439. eCollection 2015., [PMID:26327810] [PubMed]

Abstract [show]
Comments [show]
Sentences [show]